Naturally Occurring Bioactive Compound-Derived Nanoparticles for Biomedical Applications

Cited 18 time in webofscience Cited 16 time in scopus
  • Hit : 439
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorSaw, Phei Erko
dc.contributor.authorLee, Soyoungko
dc.contributor.authorJon, Sangyongko
dc.date.accessioned2020-01-29T08:20:15Z-
dc.date.available2020-01-29T08:20:15Z-
dc.date.created2020-01-29-
dc.date.created2020-01-29-
dc.date.created2020-01-29-
dc.date.created2020-01-29-
dc.date.created2020-01-29-
dc.date.issued2019-05-
dc.identifier.citationADVANCED THERAPEUTICS, v.2, no.5-
dc.identifier.issn2366-3987-
dc.identifier.urihttp://hdl.handle.net/10203/271840-
dc.description.abstractBioactive, small molecular compounds from a variety of plants and organisms have tremendous potential for use as treatments for cancer, microbial infections, inflammatory diseases, and other medical conditions. There have also been attempts to use naturally occurring bioactive compounds as delivery carriers. Such bioactive, natural compound-derived nanocarriers are expected to have better biocompatibility than synthetic material-derived drug-delivery systems and also exhibit intrinsic therapeutic efficacy. Despite these expectations, however, research on the topic is limited and thus has been the subject of very few reviews. Here, the authors describe carriers derived from four typical naturally occurring bioactive compounds-curcumin, resveratrol, epigallocatechin gallate (EGCG) (an active ingredient in green tea), and bilirubin-that have been used for biomedical applications. In this review, the pros and cons of each bioactive small molecular compound and processes for synthesizing and preparing these compound-derived delivery carriers are discussed. A number of examples that show the potential of these delivery carriers as disease treatments are considered, and their future prospects for biomedical applications are assessed. Nanoparticles that simply encapsulate or encase such bioactive compounds are outside the scope of this review and thus are not considered.-
dc.languageEnglish-
dc.publisherWILEY-
dc.titleNaturally Occurring Bioactive Compound-Derived Nanoparticles for Biomedical Applications-
dc.typeArticle-
dc.identifier.wosid000506357600002-
dc.identifier.scopusid2-s2.0-85090194048-
dc.type.rimsART-
dc.citation.volume2-
dc.citation.issue5-
dc.citation.publicationnameADVANCED THERAPEUTICS-
dc.identifier.doi10.1002/adtp.201800146-
dc.contributor.localauthorJon, Sangyong-
dc.contributor.nonIdAuthorSaw, Phei Er-
dc.contributor.nonIdAuthorLee, Soyoung-
dc.description.isOpenAccessN-
dc.type.journalArticleReview-
dc.subject.keywordAuthorBilirubin-
dc.subject.keywordAuthorcurcumin-
dc.subject.keywordAuthorEGCG-
dc.subject.keywordAuthornanoparticles-
dc.subject.keywordAuthorresveratrol-
dc.subject.keywordPlusDRUG-DELIVERY SYSTEMS-
dc.subject.keywordPlusGREEN TEA CATECHINS-
dc.subject.keywordPlusBILIRUBIN NANOPARTICLES-
dc.subject.keywordPlusIN-VITRO-
dc.subject.keywordPlusCURCUMIN NANOFORMULATIONS-
dc.subject.keywordPlusREPERFUSION INJURY-
dc.subject.keywordPlusTRANS-RESVERATROL-
dc.subject.keywordPlusHEPATIC ISCHEMIA-
dc.subject.keywordPlusBLACK PIGMENT-
dc.subject.keywordPlusCANCER-
Appears in Collection
BS-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 18 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0